Mifepristone in fibroids: Comparative study of safety and efficacy of biweekly dosage vs daily dosage schedule

• Հիմնական հեղինակներ: Neelofar Shaikh (Հեղինակ), Reeti Mehra (Հեղինակ), Poonam Goel (Հեղինակ), Ravinder Kaur (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Background: Leiomyomas are the most prevalent benign tumors of the uterus and are seen more with increasing age. 50 mg biweekly dose was compared with 25 mg daily dose in terms of efficacy and safety in symptomatic women as the biweekly dose maybe an economically better alternative. Two different do...